Genome & Co. · KRX:314130

Genome & Co. shareholders

Genome & Co. on 6ix: holders from US fund reports. Largest: Dimensional Emerging Core Equity Market ETF, Dimensional Emerging Markets Core Equity 2 ETF and Dimensional World ex. U.S. Core Equity 2 ETF. Each with its filing.

Shareholders

HolderSharesValueChangeAs of
Dimensional Emerging Core Equity Market ETF22,711US$52,249No changeJul 31, 2026
Dimensional Emerging Markets Core Equity 2 ETF18,851US$43,369NewJul 31, 2026
Dimensional World ex. U.S. Core Equity 2 ETF11,540US$26,549NewJul 31, 2026
Emerging Markets ex China Core Equity Portfolio9,104US$20,821NewJul 31, 2026
The Emerging Markets Small Cap Series4,201US$9,608−19,187Jul 31, 2026

Genome & Co. insider trades